{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T17:40:39Z","timestamp":1777052439367,"version":"3.51.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,4]]},"DOI":"10.7759\/cureus.35751","type":"journal-article","created":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T12:09:01Z","timestamp":1677931741000},"source":"Crossref","is-referenced-by-count":2,"title":["The Prevalence of Cardiovascular Manifestations in Pediatric Sickle Cell Anemia Patients in a Large Tertiary Care Hospital in the Western Region of Saudi Arabia"],"prefix":"10.7759","author":[{"given":"Rahaf","family":"Waggass","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abeer K","family":"Alhindi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inas  S","family":"Bagabas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mawaddah  H","family":"Alsaegh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noor K","family":"Alsharef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roaa E","family":"Morya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad A","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wasil","family":"Jastaniah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.10.900","article-title":"Cardiovascular abnormalities in sickle cell disease","volume":"59","author":"Gladwin MT","year":"2012","unstructured":"Gladwin MT, Sachdev V. Cardiovascular abnormalities in sickle cell disease. J Am Coll Cardiol. 2012, 59:1123-33. 10.1016\/j.jacc.2011.10.900","journal-title":"J Am Coll Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/0256-4947.81540","article-title":"Epidemiology of sickle cell disease in Saudi Arabia","volume":"31","author":"Jastaniah W","year":"2011","unstructured":"Jastaniah W. Epidemiology of sickle cell disease in Saudi Arabia. Ann Saudi Med. 2011, 31:289-93. 10.4103\/0256-4947.81540","journal-title":"Ann Saudi Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12650","article-title":"Sickle cell disease in Saudi Arabia: the phenotype in adults with the Arab-Indian haplotype is not benign","volume":"164","author":"Alsultan A","year":"2014","unstructured":"Alsultan A, Alabdulaali MK, Griffin PJ, et al.. Sickle cell disease in Saudi Arabia: the phenotype in adults with the Arab-Indian haplotype is not benign. Br J Haematol. 2014, 164:597-604. 10.1111\/bjh.12650","journal-title":"Br J Haematol"},{"key":"ref4","article-title":"Sickle cell disease","author":"Powars D","unstructured":"Powars D. Sickle cell disease. Magill\u2019s Medical Guide. 2019 (ed): Salem Press, Hackensack, NJ; 2640."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/echo.12085","article-title":"Left ventricular dyssynchrony is an early manifestation of heart involvement in sickle cell anemia","volume":"30","author":"Karaka\u015f MF","year":"2013","unstructured":"Karaka\u015f MF, B\u00fcy\u00fckkaya E, Kurt M, et al.. Left ventricular dyssynchrony is an early manifestation of heart involvement in sickle cell anemia. Echocardiography. 2013, 30:521-6. 10.1111\/echo.12085","journal-title":"Echocardiography"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz217","article-title":"Cardiovascular manifestations of sickle cell disease","volume":"41","author":"Hammoudi N","year":"2020","unstructured":"Hammoudi N, Lionnet F, Redheuil A, Montalescot G. Cardiovascular manifestations of sickle cell disease. Eur Heart J. 2020, 41:1365-73. 10.1093\/eurheartj\/ehz217","journal-title":"Eur Heart J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21058","article-title":"Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes","volume":"83","author":"De Castro LM","year":"2008","unstructured":"De Castro LM, Jonassaint JC, Graham FL, Ashley-Koch A, Telen MJ. Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes. Am J Hematol. 2008, 83:19-25. 10.1002\/ajh.21058","journal-title":"Am J Hematol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2017.1.423","article-title":"Cardiovascular complications in patients with sickle cell disease","volume":"2017","author":"Gladwin MT","year":"2017","unstructured":"Gladwin MT. Cardiovascular complications in patients with sickle cell disease. Hematology Am Soc Hematol Educ Program. 2017, 2017:423-30. 10.1182\/asheducation-2017.1.423","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/02724936.2000.11748143","article-title":"Cardiovascular function in Omani children with sickle cell anaemia","volume":"20","author":"Wali YA","year":"2000","unstructured":"Wali YA, Venugopalan P, Rivera E, al-Lamki Z. Cardiovascular function in Omani children with sickle cell anaemia. Ann Trop Paediatr. 2000, 20:243-6. 10.1080\/02724936.2000.11748143","journal-title":"Ann Trop Paediatr"},{"key":"ref10","article-title":"Cardiac manifestations of sickle cell anaemia in Sudanese children","volume":"12","author":"Ali GO","year":"2012","unstructured":"Ali GO, Abdal Gader YS, Abuzedi ES, Attalla BA. Cardiac manifestations of sickle cell anaemia in Sudanese children. Sudan J Paediatr. 2012, 12:70-8.","journal-title":"Sudan J Paediatr"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1023\/a:1016345412555","article-title":"QTc interval in the assessment of cardiac risk","volume":"6","author":"Elming H","year":"2002","unstructured":"Elming H, Brendorp B, K\u00f8ber L, Sahebzadah N, Torp-Petersen C. QTc interval in the assessment of cardiac risk. Card Electrophysiol Rev. 2002, 6:289-94. 10.1023\/a:1016345412555","journal-title":"Card Electrophysiol Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12127","article-title":"Prolongation of QTc intervals and risk of death among patients with sickle cell disease","volume":"91","author":"Upadhya B","year":"2013","unstructured":"Upadhya B, Ntim W, Brandon Stacey R, Henderson R, Leedy D, O'Brien FX, Knovich MA. Prolongation of QTc intervals and risk of death among patients with sickle cell disease. Eur J Haematol. 2013, 91:170-8. 10.1111\/ejh.12127","journal-title":"Eur J Haematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21973","article-title":"Prolonged QTc interval in children and young adults with sickle cell disease at steady state","volume":"52","author":"Liem RI","year":"2009","unstructured":"Liem RI, Young LT, Thompson AA. Prolonged QTc interval in children and young adults with sickle cell disease at steady state. Pediatr Blood Cancer. 2009, 52:842-6. 10.1002\/pbc.21973","journal-title":"Pediatr Blood Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.068965","article-title":"The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe","volume":"98","author":"Nouraie M","year":"2013","unstructured":"Nouraie M, Lee JS, Zhang Y, et al.. The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe. Haematologica. 2013, 98:464-72. 10.3324\/haematol.2012.068965","journal-title":"Haematologica"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611770","article-title":"Crizanlizumab for the prevention of pain crises in sickle cell disease","volume":"376","author":"Ataga KI","year":"2017","unstructured":"Ataga KI, Kutlar A, Kanter J, et al.. Crizanlizumab for the prevention of pain crises in sickle cell disease. N Engl J Med. 2017, 376:429-39. 10.1056\/NEJMoa1611770","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21846","article-title":"Development and validation of a pediatric severity index for sickle cell patients","volume":"85","author":"van den Tweel XW","year":"2010","unstructured":"van den Tweel XW, van der Lee JH, Heijboer H, Peters M, Fijnvandraat K. Development and validation of a pediatric severity index for sickle cell patients. Am J Hematol. 2010, 85:746-51. 10.1002\/ajh.21846","journal-title":"Am J Hematol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-1904","article-title":"Clinical practice guideline for screening and management of high blood pressure in children and adolescents","volume":"140","author":"Flynn JT","year":"2017","unstructured":"Flynn JT, Kaelber DC, Baker-Smith CM, et al.. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics. 2017, 140:e20171904. 10.1542\/peds.2017-1904","journal-title":"Pediatrics"},{"key":"ref18","unstructured":"Blood pressure Z-score application. (2021). Accessed. July 18, 2021: https:\/\/www.bcm.edu\/bodycomplab\/BPappZjs\/BPvAgeAPPz.html."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.24911\/IJMDC.51-1563490778","article-title":"Cardiac manifestations of children with sickle cell disease in Qatif area","volume":"3","author":"Alsowaiket HJ","year":"2019","unstructured":"Alsowaiket HJ, AlDabbous IA, Darwich AH, Alsultan MA, AlKhalifa AH. Cardiac manifestations of children with sickle cell disease in Qatif area. International Journal of Medicine in Developing Countries. 2019, 3:909-12. 10.24911\/IJMDC.51-1563490778","journal-title":"International Journal of Medicine in Developing Countries"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s00246-019-02202-3","article-title":"Echocardiographic screening of cardiovascular status in pediatric sickle cell disease","volume":"40","author":"Allen KY","year":"2019","unstructured":"Allen KY, Jones S, Jackson T, et al.. Echocardiographic screening of cardiovascular status in pediatric sickle cell disease. Pediatr Cardiol. 2019, 40:1670-8. 10.1007\/s00246-019-02202-3","journal-title":"Pediatr Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20866","article-title":"Evaluation of left ventricular diastolic function in pediatric sickle cell disease patients","volume":"82","author":"Zilberman MV","year":"2007","unstructured":"Zilberman MV, Du W, Das S, Sarnaik SA. Evaluation of left ventricular diastolic function in pediatric sickle cell disease patients. Am J Hematol. 2007, 82:433-8. 10.1002\/ajh.20866","journal-title":"Am J Hematol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-04-218040","article-title":"Relationship of erythropoietin, fetal hemoglobin, and hydroxyurea treatment to tricuspid regurgitation velocity in children with sickle cell disease","volume":"114","author":"Gordeuk VR","year":"2009","unstructured":"Gordeuk VR, Campbell A, Rana S, et al.. Relationship of erythropoietin, fetal hemoglobin, and hydroxyurea treatment to tricuspid regurgitation velocity in children with sickle cell disease. Blood. 2009, 114:4639-44. 10.1182\/blood-2009-04-218040","journal-title":"Blood"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s00246-007-9018-x","article-title":"Pulmonary hypertension in children and adolescents with sickle cell disease","volume":"29","author":"Onyekwere OC","year":"2008","unstructured":"Onyekwere OC, Campbell A, Teshome M, et al.. Pulmonary hypertension in children and adolescents with sickle cell disease. Pediatr Cardiol. 2008, 29:309-12. 10.1007\/s00246-007-9018-x","journal-title":"Pediatr Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/126422-the-prevalence-of-cardiovascular-manifestations-in-pediatric-sickle-cell-anemia-patients-in-a-large-tertiary-care-hospital-in-the-western-region-of-saudi-arabia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:54:34Z","timestamp":1707508474000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/126422-the-prevalence-of-cardiovascular-manifestations-in-pediatric-sickle-cell-anemia-patients-in-a-large-tertiary-care-hospital-in-the-western-region-of-saudi-arabia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,4]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.35751","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,4]]}}}